These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


380 related items for PubMed ID: 16005943

  • 21. Chromium-51-EDTA clearance in adults with a single-plasma sample.
    Mårtensson J, Groth S, Rehling M, Gref M.
    J Nucl Med; 1998 Dec; 39(12):2131-7. PubMed ID: 9867156
    [Abstract] [Full Text] [Related]

  • 22. Evaluation of glomerular filtration rate estimation by Cockcroft-Gault, Jelliffe, Wright and Modification of Diet in Renal Disease (MDRD) formulae in oncology patients.
    Ainsworth NL, Marshall A, Hatcher H, Whitehead L, Whitfield GA, Earl HM.
    Ann Oncol; 2012 Jul; 23(7):1845-53. PubMed ID: 22104575
    [Abstract] [Full Text] [Related]

  • 23. Novel algorithm for more accurate calculation of renal function in adults with cancer.
    Holweger K, Lipp HP, Dietz K, Hartmann JT, Bokemeyer C.
    Ann Pharmacother; 2008 Dec; 42(12):1749-57. PubMed ID: 19033483
    [Abstract] [Full Text] [Related]

  • 24. Carboplatin dosage formulae can generate inaccurate predictions of Carboplatin exposure in carboplatin/paclitaxel combination regimens.
    Nannan Panday VR, van Warmerdam LJ, Huizing MT, Ten Bokkel Huinink WW, Vermorken JB, Giaccone G, Veenhof CH, Schellens JH, Beijnen JH.
    Clin Drug Investig; 1998 Dec; 15(4):327-35. PubMed ID: 18370488
    [Abstract] [Full Text] [Related]

  • 25. Estimation of renal function -- what is appropriate in cancer patients?
    Barraclough LH, Field C, Wieringa G, Swindell R, Livsey JE, Davidson SE.
    Clin Oncol (R Coll Radiol); 2008 Dec; 20(10):721-6. PubMed ID: 18995170
    [Abstract] [Full Text] [Related]

  • 26. Susceptibility of glomerular filtration rate estimations to variations in creatinine methodology: a study in older patients.
    Lamb EJ, Wood J, Stowe HJ, O'Riordan SE, Webb MC, Dalton RN.
    Ann Clin Biochem; 2005 Jan; 42(Pt 1):11-8. PubMed ID: 15802027
    [Abstract] [Full Text] [Related]

  • 27. [Diabetic nephropathy: glomerular filtration rate and estimated creatinine clearance].
    Guimarães J, Bastos M, Melo M, Carvalheiro M.
    Acta Med Port; 2007 Jan; 20(2):145-50. PubMed ID: 17868520
    [Abstract] [Full Text] [Related]

  • 28. A Comparison of GFR estimating formulae based upon s-cystatin C and s-creatinine and a combination of the two.
    Tidman M, Sjöström P, Jones I.
    Nephrol Dial Transplant; 2008 Jan; 23(1):154-60. PubMed ID: 17911090
    [Abstract] [Full Text] [Related]

  • 29. Carboplatin Dosing Accuracy by Estimation of Glomerular Filtration versus Creatinuria in Cancer Patients.
    Graciano Vera N, Pino Villarreal L, Ureña Vargas J.
    Chemotherapy; 2018 Jan; 63(3):137-142. PubMed ID: 29768260
    [Abstract] [Full Text] [Related]

  • 30. Indexing glomerular filtration rate to suit children.
    Bird NJ, Henderson BL, Lui D, Ballinger JR, Peters AM.
    J Nucl Med; 2003 Jul; 44(7):1037-43. PubMed ID: 12843217
    [Abstract] [Full Text] [Related]

  • 31. Evaluation of formulas using the serum creatinine level to calculate the optimal dosage of carboplatin.
    van Warmerdam LJ, Rodenhuis S, ten Bokkel Huinink WW, Maes RA, Beijnen JH.
    Cancer Chemother Pharmacol; 1996 Jul; 37(3):266-70. PubMed ID: 8529288
    [Abstract] [Full Text] [Related]

  • 32. Lean body mass-adjusted Cockcroft and Gault formula improves the estimation of glomerular filtration rate in subjects with normal-range serum creatinine.
    Lim WH, Lim EM, McDonald S.
    Nephrology (Carlton); 2006 Jun; 11(3):250-6. PubMed ID: 16756641
    [Abstract] [Full Text] [Related]

  • 33. Formulae recently proposed to estimate renal glomerular filtration rate improve the prediction of carboplatin clearance.
    White-Koning M, Paludetto MN, Le Louedec F, Gladieff L, Chevreau C, Chatelut E, Puisset F.
    Cancer Chemother Pharmacol; 2020 Mar; 85(3):585-592. PubMed ID: 31915969
    [Abstract] [Full Text] [Related]

  • 34. What is the most appropriate formula to use in estimating glomerular filtration rate in adult Arabs without kidney disease?
    Al-Khader AA, Tamim H, Sulaiman MH, Jondeby MS, Taher S, Hejaili FF, Ghamdi G, Flaiw A, Hakami A.
    Ren Fail; 2008 Mar; 30(2):205-8. PubMed ID: 18300122
    [Abstract] [Full Text] [Related]

  • 35. Efficacy of 51Cr-EDTA clearance to tailor a carboplatin therapeutic regimen in ovarian cancer patients.
    Martino G, Frusciante V, Varraso A, Barbano F, Capotorto A, Dicembrino F, Petruzzelli F, Rubini G.
    Anticancer Res; 1999 Mar; 19(6C):5587-91. PubMed ID: 10697623
    [Abstract] [Full Text] [Related]

  • 36. [Evaluation of expected AUC of carboplatin (CBDCA) predicted by Chatelut's formula in comparison with Calvert's].
    Nakamura T, Onishi Y, Kono T, Maeda T, Wada T, Hatae M.
    Gan To Kagaku Ryoho; 1997 Mar; 24(5):579-83. PubMed ID: 9087291
    [Abstract] [Full Text] [Related]

  • 37. [Estimating renal function based on creatinine clearance: application of different formulas and correction for obese patients].
    Apperloo JJ, Gerlag PG, Beerenhout CH, Vader HL.
    Ned Tijdschr Geneeskd; 2007 May 05; 151(18):1016-23. PubMed ID: 17508688
    [Abstract] [Full Text] [Related]

  • 38. [Determination of renal function in clinical routine: which is the best method?].
    Saile P, Fiedler R, Markau S, Kuhn C, Osten B.
    Dtsch Med Wochenschr; 2007 May 18; 132(20):1093-7. PubMed ID: 17492567
    [Abstract] [Full Text] [Related]

  • 39. [Differences between the glomerular filtration rate estimated by the MDRD equation and the measurement of creatinine and urea clearance in unselected patients with terminal renal insufficiency].
    Caravaca F, Arrobas M, Luna E, Naranjo M, Pizarro JL, Sánchez-Casado E.
    Nefrologia; 2002 May 18; 22(5):432-7. PubMed ID: 12497744
    [Abstract] [Full Text] [Related]

  • 40. Multi-center study of two dose levels of paclitaxel with carboplatin in locally advanced and metastatic non-small cell lung cancer (NSCLC).
    Glorieux P, Ortmanns P, Marien S, Degives R, Degraeve D, Potvin M, Grauwels D, Schallier D.
    Anticancer Res; 2001 May 18; 21(2B):1487-94. PubMed ID: 11396237
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 19.